The shared care responsibility of prescribing involves the transfer of clinical responsibility from a hospital or specialist service to general practice, in which the patient’s GP is supported by a shared care agreement.
When a specialist considers a patient’s condition to be stable or predictable, they may seek the agreement of the GP concerned, and the patient, to take over responsibility for prescribing. The guidelines are intended to support the transfer of prescribing responsibility between the specialist and GP and act as an information resource to support clinicians which specifies the responsibilities of those involved in the patients care. They do not replace the need for good communication between the specialist and GP about sharing care for the individual patient.
New shared care guidelines should be proposed at the HIOW Precribing Committee to allow specialists and GPs to decide on the need of a shared care guideline.
Shared Care Guidelines approved for use across HIOW Integrated Care System:
- Atomoxetine for patients with Attention Hyperactivity Disorder (ADHD) in adults and children
- Dexamfetamine for patients within adult and children services
- Guanfacine for patients within adult and children services
- Lisdexamfetamine for patients within adult and children services
- Methylphenidate for patients within adult and children services
- Azathioprine and mercaptopurine for patients within adult services (non-transplant indications)
- Ciclosporin (oral) for patients within adult services (non-transplant indications)
- Hydroxychloroquine for patients within adult services
- Leflunomide for patients within adult services
- Methotrexate (oral and subcutaneous) for patients in adult services (excluding cancer care)
- Mycophenolate mofetil and mycophenolic acid for patients within adult services (non-transplant indications)
- Sulfasalazine for patients within adult services
The HIOW PC is newly formed from the existing prescribing committees within the HIOW area. Therefore, shared care guidelines agreed by previous committees within these areas are currently under review to make them HIOW wide. In the meantime they will continue to be active and can be found below.
Mental Health/Inclusion
Miscellaneous
- Adjuvant bisphosphonates for early breast cancer
- Clomifene
- Enoxaparin
- Lanreotide and Octreotide LA
- Liothyronine adults with Hypothyroidism
- Liothyronine prior approval form
- Prucalopride
- Rifaximin
- Safinamide in Parkinson's Disease
- Sativex
- Sildenafil Raynauds
- Stiripentol for Dravet syndrome
For medicines used in mental health services provided by Hampshire and Isle of Wight Healthcare NHS Foundation Trust, the shared care guidelines are hosted on the Hampshire and Isle of Wight Healthcare NHS Foundation Trust website.